CRISPR Therapeutics AG (CRSP)
43.44
+0.30 (+0.68%)
USD |
NASDAQ |
Mar 24, 16:00
43.43
0.00 (0.00%)
After-Hours: 18:09
CRISPR Therapeutics Price to Book Value: 1.821 for March 24, 2023
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 23, 2023 | 1.809 |
| March 22, 2023 | 1.826 |
| March 21, 2023 | 1.890 |
| March 20, 2023 | 1.864 |
| March 17, 2023 | 1.918 |
| March 16, 2023 | 1.903 |
| March 15, 2023 | 1.884 |
| March 14, 2023 | 1.893 |
| March 13, 2023 | 1.917 |
| March 10, 2023 | 1.812 |
| March 09, 2023 | 1.920 |
| March 08, 2023 | 2.010 |
| March 07, 2023 | 2.006 |
| March 06, 2023 | 2.069 |
| March 03, 2023 | 2.132 |
| March 02, 2023 | 2.063 |
| March 01, 2023 | 2.001 |
| February 28, 2023 | 2.068 |
| February 27, 2023 | 2.062 |
| February 24, 2023 | 2.014 |
| February 23, 2023 | 2.098 |
| February 22, 2023 | 2.113 |
| February 21, 2023 | 1.955 |
| February 17, 2023 | 2.134 |
| February 16, 2023 | 2.119 |
| Date | Value |
|---|---|
| February 15, 2023 | 2.184 |
| February 14, 2023 | 2.130 |
| February 13, 2023 | 2.156 |
| February 10, 2023 | 2.084 |
| February 09, 2023 | 2.138 |
| February 08, 2023 | 2.235 |
| February 07, 2023 | 2.330 |
| February 06, 2023 | 2.324 |
| February 03, 2023 | 2.314 |
| February 02, 2023 | 2.349 |
| February 01, 2023 | 2.191 |
| January 31, 2023 | 2.136 |
| January 30, 2023 | 2.092 |
| January 27, 2023 | 2.210 |
| January 26, 2023 | 2.113 |
| January 25, 2023 | 2.124 |
| January 24, 2023 | 2.175 |
| January 23, 2023 | 2.148 |
| January 20, 2023 | 2.077 |
| January 19, 2023 | 1.996 |
| January 18, 2023 | 2.116 |
| January 17, 2023 | 2.167 |
| January 13, 2023 | 2.091 |
| January 12, 2023 | 2.079 |
| January 11, 2023 | 2.024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.492
Minimum
May 09 2022
13.10
Maximum
Mar 26 2018
4.795
Average
4.472
Median
Jun 03 2020
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.815 |
| Intellia Therapeutics Inc | 2.728 |
| Beam Therapeutics Inc | 3.002 |
| Editas Medicine Inc | 1.430 |
| AC Immune SA | 1.021 |
Price to Book Value Related Metrics
| PS Ratio | 7744.98 |
| Price | 43.44 |
| Earnings Yield | -19.27% |
| Market Cap | 3.416B |